🇺🇸 Ginkgo Biloba Extract in United States
209 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 209
Most-reported reactions
- Drug Interaction — 35 reports (16.75%)
- Fall — 31 reports (14.83%)
- Hypertension — 19 reports (9.09%)
- Arrhythmia — 18 reports (8.61%)
- Asthenia — 18 reports (8.61%)
- Confusional State — 18 reports (8.61%)
- Drug Ineffective — 18 reports (8.61%)
- Fatigue — 18 reports (8.61%)
- Dizziness — 17 reports (8.13%)
- Nausea — 17 reports (8.13%)
Other Neurology / Cardiovascular approved in United States
Frequently asked questions
Is Ginkgo Biloba Extract approved in United States?
Ginkgo Biloba Extract does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ginkgo Biloba Extract in United States?
Beijing HuiLongGuan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.